Several cross-sectional studies demonstrated that autoantibodies to thyroid peroxidase (TPO-Abs) are about 1–2 times more prevalent in patients with bipolar disorder (BD) than in the general population (Kupka et al. 2002; Chakrabarti 2011; Bergink et al. 2013). The gene discussed is TPO; the disease is bipolar disorder.